• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 469405 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416867285 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416867285 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Stock to Watch: Novabay Pharmaceuticals Up 8.6% (NBY)

Published on Mon, 04/01/2013 - 12:24
By Adrienne Chilton

Novabay Pharmaceuticals (AMEX:NBY) is one of today's best performing low-priced stocks, up 8.6% to $1.52 on 3.8x average daily volume. Thus far today, Novabay Pharmaceuticals has traded 921,000 shares, vs. average volume of 240,000 shares per day. The stock has outperformed the Dow (8.6% to the Dow's -0.0%) and outperformed the S&P 500 (8.6% to the S&P's -0.4%) during today's trading.

Potential upside of 48.0% exists for Novabay Pharmaceuticals, based on a current level of $1.52 and analysts' average consensus price target of $2.25. The stock should find initial support at its 200-day moving average (MA) of $1.25 and further support at its 50-day MA of $1.24.

Novabay Pharmaceuticals Inc. is a biopharmaceutical company focused on developing product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. The Company has developed a class of antimicrobial compounds for use in the treatment and prevention of bacterial infections.

In the past 52 weeks, Novabay Pharmaceuticals share prices have been bracketed by a low of $0.88 and a high of $1.76 and are now at $1.52, 73% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 1.0%.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Shares of Weyerhaeuser Rise Above Previo...

Shares of Weyerhaeuser (NYSE:WY) traded at a new 52-week high today of $34.76. Approxi ...

Watch for Continued Gains in Shares of V...

Shares of VCA Antech (NASDAQ:WOOF) traded today at $47.00, breaking its 52-week high. ...

Recent 52-Week High Exceeded in Shares o...

Wells Fargo (NYSE:WFC) traded today at a new 52-week high of $54.36. Approximately 6.7 ...

Watch for Continued Gains in Shares of W...

Wabtec (NYSE:WAB) traded at a new 52-week high today of $91.14. So far today approxima ...

Ventas: 52-Week High Recently Eclipsed (...

Shares of Ventas (NYSE:VTR) traded today at $69.92, breaking its 52-week high. This ne ...

Recent 52-Week High Exceeded in Shares o...

Validus Holdings (NYSE:VR) traded today at a new 52-week high of $41.40. This new high ...

US Bancorp Looks to Continue to Trade Ab...

US Bancorp (NYSE:USB) traded today at a new 52-week high of $44.49. Approximately 3.2 ...

Union Pacific Looks to Continue to Trade...

Shares of Union Pacific (NYSE:UNP) traded at a new 52-week high today of $123.37. Appr ...